Ken Fisher's GILD Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 24,435 shares of Gilead Sciences, Inc. (GILD) worth $3 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in GILD, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 373,725 shares. Largest reduction occurred in Q1 2020, reducing 500,913 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +1.04 M | Add 0.00% | 1.04 M | $51.27 |
| Q3 2013 | -60,010 | Reduce 5.78% | 977,358 | $62.87 |
| Q4 2013 | -44,103 | Reduce 4.51% | 933,255 | $75.10 |
| Q1 2014 | -331,497 | Reduce 35.52% | 601,758 | $70.86 |
| Q2 2014 | +373,725 | Add 62.11% | 975,483 | $82.91 |
| Q3 2014 | -212,060 | Reduce 21.74% | 763,423 | $106.45 |
| Q4 2014 | +8,078 | Add 1.06% | 771,501 | $94.26 |
| Q1 2015 | +18,114 | Add 2.35% | 789,615 | $98.13 |
| Q2 2015 | +2,015 | Add 0.26% | 791,630 | $117.08 |
| Q3 2015 | -229,239 | Reduce 28.96% | 562,391 | $98.19 |
| Q4 2015 | +1,526 | Add 0.27% | 563,917 | $101.19 |
| Q1 2016 | -76,887 | Reduce 13.63% | 487,030 | $98.29 |
| Q2 2016 | -40,537 | Reduce 8.32% | 446,493 | $86.25 |
| Q3 2016 | -1,964 | Reduce 0.44% | 444,529 | $79.12 |
| Q4 2016 | +10,967 | Add 2.47% | 455,496 | $71.61 |
| Q1 2017 | -3,862 | Reduce 0.85% | 451,634 | $67.92 |
| Q2 2017 | +8,521 | Add 1.89% | 460,155 | $70.78 |
| Q3 2017 | +9,245 | Add 2.01% | 469,400 | $81.02 |
| Q4 2017 | -26,626 | Reduce 5.67% | 442,774 | $71.64 |
| Q1 2018 | +85,685 | Add 19.35% | 528,459 | $75.39 |
| Q2 2018 | +31,109 | Add 5.89% | 559,568 | $70.84 |
| Q3 2018 | -13 | Reduce 0.00% | 559,555 | $77.21 |
| Q4 2018 | +38,205 | Add 6.83% | 597,760 | $62.55 |
| Q1 2019 | +18,041 | Add 3.02% | 615,801 | $65.01 |
| Q2 2019 | +7,250 | Add 1.18% | 623,051 | $67.56 |
| Q3 2019 | +29,203 | Add 4.69% | 652,254 | $63.38 |
| Q4 2019 | -146,467 | Reduce 22.46% | 505,787 | $64.98 |
| Q1 2020 | -500,913 | Reduce 99.04% | 4,874 | $74.68 |
| Q2 2020 | -1,390 | Reduce 28.52% | 3,484 | $76.92 |
| Q3 2020 | +3,213 | Add 92.22% | 6,697 | $63.16 |
| Q4 2020 | +2,667 | Add 39.82% | 9,364 | $58.31 |
| Q1 2021 | -101 | Reduce 1.08% | 9,263 | $64.67 |
| Q2 2021 | -260 | Reduce 2.81% | 9,003 | $68.87 |
| Q3 2021 | -1,091 | Reduce 12.12% | 7,912 | $69.89 |
| Q4 2021 | +340 | Add 4.30% | 8,252 | $72.59 |
| Q1 2022 | -1,884 | Reduce 22.83% | 6,368 | $59.52 |
| Q2 2022 | +5,397 | Add 84.75% | 11,765 | $61.79 |
| Q3 2022 | +1,880 | Add 15.98% | 13,645 | $61.71 |
| Q4 2022 | -761 | Reduce 5.58% | 12,884 | $85.84 |
| Q1 2023 | -1,281 | Reduce 9.94% | 11,603 | $82.97 |
| Q2 2023 | +2,105 | Add 18.14% | 13,708 | $77.07 |
| Q3 2023 | -26 | Reduce 0.19% | 13,682 | $74.94 |
| Q4 2023 | -1,376 | Reduce 10.06% | 12,306 | $81.01 |
| Q1 2024 | +788 | Add 6.40% | 13,094 | $73.26 |
| Q2 2024 | +110 | Add 0.84% | 13,204 | $68.61 |
| Q3 2024 | -4,254 | Reduce 32.22% | 8,950 | $83.85 |
| Q4 2024 | +1,656 | Add 18.50% | 10,606 | $92.38 |
| Q1 2025 | -3,656 | Reduce 34.47% | 6,950 | $112.06 |
| Q2 2025 | +3,750 | Add 53.96% | 10,700 | $110.87 |
| Q3 2025 | +15,352 | Add 143.48% | 26,052 | $111.00 |
| Q4 2025 | -1,617 | Reduce 6.21% | 24,435 | $122.74 |
Ken Fisher's Gilead Sciences Investment FAQs
Ken Fisher first purchased Gilead Sciences, Inc. (GILD) in Q2 2013, acquiring 1,037,368 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Gilead Sciences, Inc. (GILD) for 51 quarters since Q2 2013.
Ken Fisher's largest addition to Gilead Sciences, Inc. (GILD) was in Q2 2013, adding 1,037,368 shares worth $53.19 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 24,435 shares of Gilead Sciences, Inc. (GILD), valued at approximately $3 M.
As of the Q4 2025 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Gilead Sciences, Inc. (GILD) was 1,037,368 shares, as reported at the end of Q2 2013.